Results show the regimen of epcoritamab plus R-ICE could serve most patients as a bridge to either autologous stem cell ...

Tabelecleucel shows promising efficacy in treating EBV-positive PTLD, offering hope for patients resistant to previous ...

Epkinly (epcoritamab) is a subcutaneously delivered CD3×CD20 BiTE that secured FDA accelerated approval in 2023 for r/r DLBCL.

The BM12 CAST trial, a major clinical trial led by the Australasian Leukaemia & Lymphoma Group (ALLG) across New Zealand and Australian hospitals, will transform global blood stem cell transplant ...

By the end of the 4-0 loss to the Atlanta Braves in the opener of a four-game series, his arm was in a splint, and he was preparing for a flight back to Cincinnati Tuesday morning for surgery.

Last fall, the 29-year-old came to the Hospital of the University of Pennsylvania from his home in Switzerland for a rare ...

Rates of grade III/IV acute GVHD at 3 months were 3% with cyclophosphamide-cyclosporin prophylaxis and 10% with standard prophylaxis, reported David Curtis, MBBS, PhD, of Alfred H ...

Two posters presented at the 2025 European Hematology Association Congress support combination therapy with daratumumab, ...

Javascript must be enabled to use this site. Please enable Javascript in your browser and try again. The Cash Hacks Challenge could help you save money and build ...

This repository provides access to the IAR Build Tools for Arm, for easy integration into cloud-based environments and modern development workflows.

A phase 3 trial did not support a transplant-based approach for patients who already achieved MRD negativity or a tandem ...

Clarks Summit resident Courtenay Degnon considers herself a typical mom of two teenagers. She works daily. She makes sure the ...